118 related articles for article (PubMed ID: 9000665)
21. A liver nodule in a patient transplanted for primary sclerosing cholangitis: an interdisciplinary diagnostic approach.
Loosen SH; Schmeding M; Roderburg C; Binnebösel M; Temizel I; Mottaghy FM; Tischendorf JJ; Tacke F; Gaisa NT; Hussein K; Lehmann U; Trautwein C; Neumann UP; Luedde T
Z Gastroenterol; 2017 Jan; 55(1):56-62. PubMed ID: 27706546
[TBL] [Abstract][Full Text] [Related]
22. Inexplicable Outcome of Early Appearance of Hepatocellular Carcinoma in the Allograft After Deceased Donor Liver Transplantation: A Case Report.
Navarro Burgos JB; Lee KW; Shin YC; Lee DS; Lee KB; Yi NJ; Suh KS
Transplant Proc; 2015 Dec; 47(10):3012-5. PubMed ID: 26707329
[TBL] [Abstract][Full Text] [Related]
23. Donor-transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: a rare indication for liver retransplantation.
Snape K; Izatt L; Ross P; Ellis D; Mann K; O'Grady J
Liver Transpl; 2008 Feb; 14(2):155-8. PubMed ID: 18236388
[No Abstract] [Full Text] [Related]
24. Post-transplant lymphoma in a liver allograft.
Ribas Y; Rafecas A; Figueras J; Benasco C; Fabregat J; Torras J; Cañas C; Valls C; Volpini V; Banchs I
Transpl Int; 1995; 8(6):488-91. PubMed ID: 8579742
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.
Palombo JD; Burke PA; Moldawer LL; Forse RA; Lewis WD; Jenkins RL
J Am Coll Surg; 1994 Aug; 179(2):209-19. PubMed ID: 7519108
[TBL] [Abstract][Full Text] [Related]
27. Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
Flemming P; Tillmann HL; Barg-Hock H; Kleeberger W; Manns MP; Klempnauer J; Kreipe HH
Transplantation; 2003 Sep; 76(5):871-3. PubMed ID: 14501871
[TBL] [Abstract][Full Text] [Related]
28. Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation.
Florman S; Bowne W; Kim-Schluger L; Sung MW; Huang R; Fotino M; Thung S; Schwartz M; Miller C
Am J Transplant; 2004 Feb; 4(2):278-82. PubMed ID: 14974952
[TBL] [Abstract][Full Text] [Related]
29. High frequency of chimerism in transplanted livers.
Ng IO; Chan KL; Shek WH; Lee JM; Fong DY; Lo CM; Fan ST
Hepatology; 2003 Oct; 38(4):989-98. PubMed ID: 14512886
[TBL] [Abstract][Full Text] [Related]
30. Recipient-derived hepatocytes in liver transplants: a rare event in sex-mismatched transplants.
Fogt F; Beyser KH; Poremba C; Zimmerman RL; Khettry U; Ruschoff J
Hepatology; 2002 Jul; 36(1):173-6. PubMed ID: 12085362
[TBL] [Abstract][Full Text] [Related]
31. In situ hybridization utilizing a Y chromosome DNA probe. Use as a cell marker for hepatocellular transplantation.
Eckert JW; Buerkle CJ; Major AM; Finegold MJ; Brandt ML
Transplantation; 1995 Jan; 59(1):109-11. PubMed ID: 7839410
[TBL] [Abstract][Full Text] [Related]
32. Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation.
Vernadakis S; Poetsch M; Weber F; Treckmann J; Mathe Z; Baba HA; Paul A; Kaiser GM
Transpl Int; 2010 Mar; 23(3):341-3. PubMed ID: 19737373
[No Abstract] [Full Text] [Related]
33. Donor-derived acute promyelocytic leukemia in a liver-transplant recipient.
Bodó I; Peters M; Radich JP; Hess J; Blinder M; Watson MS; Van Rheeden R; Natarajan S; Lowell JA; Brown R; DiPersio J; Adkins D
N Engl J Med; 1999 Sep; 341(11):807-13. PubMed ID: 10477779
[No Abstract] [Full Text] [Related]
34. Hepatic localization of a fibrosarcoma in a child with a liver transplant.
Danhaive O; Ninane J; Sokal E; Latinne D; Philippe M; Gosseye S; Clapuyt P; Otte JB
J Pediatr; 1992 Mar; 120(3):434-7. PubMed ID: 1538293
[TBL] [Abstract][Full Text] [Related]
35. Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens.
Meves A; el-Azhary RA; Talwalkar JA; Moore SB; Brewer JD; Motsonelidze C; McNallan KT; Reed AM; Rosen CB
J Am Acad Dermatol; 2006 Oct; 55(4):642-6. PubMed ID: 17010745
[TBL] [Abstract][Full Text] [Related]
36. De novo sarcoma of donor origin in a liver allograft determined by microsatellite analysis: a short report.
Chan SC; Cheung ST; Leung SY; Liu CL; Fan ST; Lo CM
Liver Transpl; 2004 Feb; 10(2):320-3. PubMed ID: 14762874
[TBL] [Abstract][Full Text] [Related]
37. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications.
John BV; Aiken T; Garber A; Thomas D; Lopez R; Patil D; Konjeti VR; Fung JJ; McCollough AJ; Askar M
Exp Clin Transplant; 2018 Aug; 16(4):439-445. PubMed ID: 29863454
[TBL] [Abstract][Full Text] [Related]
38. Identification of host and donor cells in porcine homograft heart valve explants by fluorescence in situ hybridization.
Braun J; Hazekamp MG; Koolbergen DR; Sugihara H; Goffin YA; Huysmans HA; Cornelisse CJ
J Pathol; 1997 Sep; 183(1):99-104. PubMed ID: 9370954
[TBL] [Abstract][Full Text] [Related]
39. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
40. Death from metastatic donor-derived ovarian cancer in a male kidney transplant recipient.
Lipshutz GS; Mihara N; Wong R; Wallace WD; Allen-Auerbach M; Dorigo O; Rao PN; Pham PC; Pham PT
Am J Transplant; 2009 Feb; 9(2):428-32. PubMed ID: 19178417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
